You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
AstraZeneca
Johnson and Johnson
Harvard Business School
Moodys

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018009


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 018009 describes SARENIN, which is a drug marketed by Procter And Gamble and is included in one NDA. Additional details are available on the SARENIN profile page.

The generic ingredient in SARENIN is saralasin acetate. Additional details are available on the saralasin acetate profile page.
Summary for 018009
Tradename:SARENIN
Applicant:Procter And Gamble
Ingredient:saralasin acetate
Patents:0
Medical Subject Heading (MeSH) Categories for 018009

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 0.6MG BASE/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 018009

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Procter And Gamble SARENIN saralasin acetate INJECTABLE;INJECTION 018009-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Procter And Gamble SARENIN saralasin acetate INJECTABLE;INJECTION 018009-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
McKesson
Johnson and Johnson
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.